MedTrace Logo

Bedside Evaluation of Coagulation in Children With Congenital Heart Disease

NCT02387944 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-01-26

No results posted yet for this study

Summary

The purpose of this study is to assess coagulation and platelet function in children with congenital heart disease, measured with a bedside device (thromboelastometry and impedance aggregometry).

The investigators also aim to determine if this device detect post-cardiopulmonary bypass clotting derangements and may help to manage bleeding in this population.

Conditions

  • Congenital Heart Defect
  • Blood Coagulation Disorder

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Vaudois

    lead OTHER

Principal Investigators

  • Stefano Di Bernardo, MD · CHUV

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-07-06
Completion
2017-07-07

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02387944 on ClinicalTrials.gov